Caidya & Simbec-Orion announce strategic combination. Learn More
We know that sharing the power of our knowledge delivers real transformation for our clients. Our leadership team is actively engaged in our services and accessible to our clients, working as one to unlock the hidden potential in our clients’ science and helping to shape a better future, one study at a time.
Barbara Lopez Kunz is Chief Executive Officer of Caidya and a global healthcare and life sciences executive with more than 30 years of leadership experience spanning clinical research, diagnostics, medical devices, biopharma, and public health. She has served on Caidya’s Board of Directors since 2022 and has played a key role in shaping the company’s governance, strategy, and growth.
Prior to joining Caidya, Barbara served as President and Chief Executive Officer of the Drug Information Association (DIA), where she led a significant digital and organizational transformation. Previously, she held senior executive leadership roles at Battelle, Thermo Fisher Scientific, DuPont, and ICI (now AstraZeneca), leading global businesses, driving growth, advancing innovation, and building high-performing organizations across international markets.
Barbara serves on the boards of Werfen and Aptevo Therapeutics and is Vice Chair of the Board of Children’s National Hospital. She holds a Master of Science in Polymer Science from The University of Akron, completed the International Executive Programme at INSEAD, is a DIA Fellow, and is a Certified Director through the National Association of Corporate Directors (NACD).
Michael Clay serves as Chief Operating Officer of Caidya and leads the Global Operations Leadership Team, with responsibility for operational delivery, client engagement, and the company’s global operating model. He combines strategic oversight with operational leadership to drive performance, innovation, and execution excellence across global clinical development programs for biotechnology and pharmaceutical sponsors.
Michael brings extensive experience leading large-scale global clinical trial programs across more than 60 countries, including significant experience throughout the Asia-Pacific region. He lived and worked in China and Singapore for many years leading Clinical development. Throughout his career, he has built and scaled high-performing delivery organizations recognized for operational rigor, quality execution, and strong sponsor partnerships. Prior to joining Caidya, he served as Senior Vice President, Global Project Delivery at a large CRO, where he oversaw the delivery of more than 500 global clinical trials. Michael’s earlier leadership roles were at key, global research organizations where his responsibilities spanned clinical development, therapeutic delivery, site relationship development, and biotechnology and pharmaceutical engagement strategies.
Michael holds a Master of Science in Jurisprudence in Pharmaceutical and Medical Device Law from Seton Hall University School of Law and a Bachelor of Science in Biology and Chemistry from Missouri State University.
Miron Lila is Chief Corporate Development Officer at Caidya. In this role, he is responsible for supporting key financing and strategic initiatives, identifying partnership opportunities to accelerate the company’s global growth, coordinating investor communication efforts, and working with the senior management team to build a robust investor relations strategy. Additionally, he oversees Caidya’s global Accounting/Reporting and Treasury functions.
With over seventeen years of healthcare-focused corporate finance, capital markets, and mergers and acquisitions experience, Miron brings a wealth of expertise to his role. Prior to joining Caidya, he served as a senior healthcare investment banker and team head at Citi, where he played a key role in establishing Citi’s healthcare franchise in Asia. During his tenure, Miron developed a broad spectrum of senior-level client and industry relationships in the biopharma & healthcare sector, with a unique geographic scope covering Greater China, Korea, and Southeast Asia. He successfully completed over 30 transactions across all investment banking products, amounting to a total deal value of US$15 billion.
Miron holds a BSc. in Government and Economics from the London School of Economics and Political Science. He is also a member of the Hong Kong Stock Exchange Listing Committee, which acts as both an independent administrative decision-maker and an advisory body for the Exchange, where he was appointed in July 2022.
John Scott serves as Chief Information Officer at Caidya, where he leads the company’s global technology strategy, digital enablement initiatives, and enterprise platforms that support the delivery of high-quality clinical research services worldwide. He partners closely with operational and business leaders to align scalable global technology solutions with compliant regional processes, enabling study execution, regulatory readiness, and an exceptional experience for sponsors across Caidya’s global CRO network.
Through a focus on innovation, operational excellence, and data-driven decision-making, John helps position Caidya to meet the evolving needs of sponsors and accelerate the successful delivery of clinical development programs in an increasingly complex research landscape.
John brings more than two decades of executive leadership experience across the biotechnology and clinical research industries. His experience spans global organizations, including GSK, Pfizer, Bayer, and Amgen, as well as private equity-backed life sciences companies, where he has led technology, regulatory, and business transformation initiatives that strengthen clinical delivery, enhance quality and compliance, and drive scalable growth in support of customers and patients.
Yingshi Qian serves as Senior Vice President, Global Human Resources at Caidya and leads talent acquisition, talent management, organizational development, training, benefits, and global compensation strategies.
Yingshi brings more than 20 years of human resources experience across the biopharmaceutical and financial services industries. Prior to joining Caidya, she held HR leadership roles supporting business start-up, rapid expansion, career framework development for R&D professionals, regional hub creation, and leadership development programs.
Yingshi’s expertise spans workforce planning, organizational effectiveness, leadership development, and global talent strategy. She holds an MBA from the University of Strathclyde Graduate School of Business.